Armata Pharmaceuticals (ARMP) Shares Outstanding (Weighted Average) (2016 - 2026)
Quarterly results put Shares Outstanding (Weighted Average) at $36.5 million for Q1 2026, up 0.95% from a year ago — trailing twelve months through Mar 2026 was $36.5 million (up 0.95% YoY), and the annual figure for FY2025 was $36.2 million, changed 0.22%.
Armata Pharmaceuticals has reported Shares Outstanding (Weighted Average) over the past 14 years, most recently at $36.5 million for Q1 2026.
- Shares Outstanding (Weighted Average) reached $36.5 million in Q1 2026 per ARMP's latest filing, up from $36.2 million in the prior quarter.
- Across five years, Shares Outstanding (Weighted Average) topped out at $36.5 million in Q1 2026 and bottomed at $20.5 million in Q3 2022.
- Median Shares Outstanding (Weighted Average) over the past 5 years was $36.1 million (2024), compared with a mean of $34.7 million.
- The largest annual shift saw Shares Outstanding (Weighted Average) soared 75.61% in 2023 before it rose 0.11% in 2025.
- Over 5 years, Shares Outstanding (Weighted Average) stood at $34.3 million in 2022, then grew by 5.19% to $36.1 million in 2023, then increased by 0.24% to $36.2 million in 2024, then increased by 0.22% to $36.2 million in 2025, then rose by 0.8% to $36.5 million in 2026.
- Business Quant data shows Shares Outstanding (Weighted Average) for ARMP at $36.5 million in Q1 2026, $36.2 million in Q4 2025, and $36.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 177,333.76 Bn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 185,491.37 Bn |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 100.00 Bn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 55.66 Bn |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 118.76 Bn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 254.10 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 104.00 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 16.04 Bn |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 132.89 Mn |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - | 36.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 36.53 Mn |
| Dec 31, 2025 | 36.24 Mn |
| Sep 30, 2025 | 36.20 Mn |
| Jun 30, 2025 | 36.19 Mn |
| Mar 31, 2025 | 36.18 Mn |
| Dec 31, 2024 | 36.16 Mn |
| Sep 30, 2024 | 36.15 Mn |
| Jun 30, 2024 | 36.15 Mn |
| Mar 31, 2024 | 36.12 Mn |
| Dec 31, 2023 | 36.08 Mn |
| Sep 30, 2023 | 36.09 Mn |
| Jun 30, 2023 | 36.06 Mn |
| Mar 31, 2023 | 36.05 Mn |
| Dec 31, 2022 | 34.29 Mn |
| Sep 30, 2022 | 20.55 Mn |
| Jun 30, 2022 | 36.00 Mn |
| Mar 31, 2022 | 29.00 Mn |
| Dec 31, 2021 | 24.10 Mn |
| Sep 30, 2021 | 16.65 Mn |
| Jun 30, 2021 | 22.62 Mn |
| Mar 31, 2021 | 20.46 Mn |
| Dec 31, 2020 | 16.42 Mn |
| Sep 30, 2020 | 10.55 Mn |
| Jun 30, 2020 | 14.40 Mn |
| Mar 31, 2020 | 10.45 Mn |
| Dec 31, 2019 | 7.83 Mn |
| Sep 30, 2019 | 7.25 Mn |
| Jun 30, 2019 | 1.85 Mn |
| Mar 31, 2019 | 4.65 Mn |
| Dec 31, 2018 | 4.65 Mn |
| Sep 30, 2018 | 15.42 Mn |
| Jun 30, 2018 | 14.89 Mn |
| Mar 31, 2018 | 13.30 Mn |
| Dec 31, 2017 | 6.39 Mn |
| Sep 30, 2017 | 8.87 Mn |
| Jun 30, 2017 | 5.35 Mn |
| Mar 31, 2017 | 1.68 Mn |
| Dec 31, 2016 | 983,846.00 |
| Sep 30, 2016 | 1.11 Mn |
| Jun 30, 2016 | 874,062.00 |